ASCP Corner February 4, 2020

Evidence-Based Treatment of Premenstrual Dysphoric Disorder: A Concise Review

Sara V. Carlini, MD; Kristina M. Deligiannidis, MD

J Clin Psychiatry 2020;81(2):19ac13071

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Premenstrual dysphoric disorder (PMDD) is a collection of physical, cognitive, and affective symptoms causing clinically significant distress or interference that occur in the 7 days prior to the onset of menses, after which they become minimal or absent. The diagnosis is established by symptom documentation using a validated, reliable tool such as the Daily Record of Severity of Problems (DRSP) for at least 2 menstrual cycles to confirm the timing of relevant symptoms. According to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), there is a 1.8%-5.8% 12-month prevalence of PMDD among menstruating women1; however, the prevalence of premenstrual symptoms causing clinically significant interference or distress but not meeting full criteria for a diagnosis of PMDD may be as high as 13%-18%.

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.